Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Troikaa Pharmaceuticals is a research-driven Indian pharmaceutical company specializing in the development of innovative drug delivery systems and high-quality generic formulations. The company is globally recognized for its breakthrough innovations in pain management, most notably Dynapar AQ, the world's first painless diclofenac injection. Troikaa operates state-of-the-art manufacturing facilities that adhere to international regulatory standards, including WHO-GMP and ISO certifications. Their diverse product portfolio spans critical care, anesthesia, orthopedics, and gynecology, with a commercial presence in over 70 countries. By focusing on proprietary technology platforms like QPS (Quick Penetrating Solution), Troikaa continues to enhance the efficacy and safety profiles of established therapeutic agents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Troikaa Parenterals.